The Efficacy of Group-based Unified Protocol (UP) Programme for Improving Sleep and Mental Health
1 other identifier
interventional
80
1 country
1
Brief Summary
Common mental disorders can be disabling and lead to a large burden of disease. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders was developed to address emotional disorders with evidence-based emotional-focused cognitive-behavioural techniques and is efficacious in reducing anxiety symptoms and depressive symptoms in adults. Previous research has demonstrated comparable effect of UP on reducing anxiety symptoms compared with the single-disorder protocol (SDP) for anxiety. Group-based UP was also implemented and tested. Given the fact that working populations are at a high risk of poor mental health, especially in light of the COVID pandemic with new unprecedented work situations and increased uncertainties, the present study aims to investigate the efficacy of Unified protocol on sleep and mental health in high-risk population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable quality-of-life
Started Nov 2021
Typical duration for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
May 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMay 27, 2022
May 1, 2022
1.5 years
February 14, 2022
May 23, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Positive affect
Positive and Negative Affect Schedule (PANAS), 4 items, 5-point Likert scale ranging from 1 (never) to 5 (always)
week 1, week 5, week 9, 12 weeks after completion of intervention
Change in Negative affect
Positive and Negative Affect Schedule (PANAS), 4 items, 5-point Likert scale ranging from 1 (never) to 5 (always)
week 1, week 5, week 9, 12 weeks after completion of intervention
Change of insomnia symptoms
Insomnia symptoms are measured by Insomnia Severity Index (ISI). ISI is a 5-item self-rated scale. Possible scores range from 0 to 20, with higher scores indicating higher insomnia severity.
week 1, week 5, week 9, 12 weeks after completion of intervention
Secondary Outcomes (26)
Change of Sleep Diary Measure - Time in Bed (TIB)
week 1, week 9, 12 weeks after completion of intervention
Change of Sleep Diary Measure - Total Sleep Time (TST)
week 1, week 9, 12 weeks after completion of intervention
Change of Sleep Diary Measure - Sleep Onset Latency (SOL)
week 1, week 9, 12 weeks after completion of intervention
Change of Sleep Diary Measure - Wake After Sleep Onset (WASO)
week 1, week 9, 12 weeks after completion of intervention
Change of Sleep Diary Measure - Sleep Efficiency (SE)
week 1, week 9, 12 weeks after completion of intervention
- +21 more secondary outcomes
Study Arms (2)
Unified Protocol
EXPERIMENTAL8-session group-based intervention
Wait-list control
NO INTERVENTIONParticipants in the wait-list control group will receive the same program, two months after their counterparts in the experimental group completed the intervention.
Interventions
The group-based UP is structured and manualized and consists of 9 1.5 hours weekly sessions (90-min, 18 participants in each group). The group-based UP is a course consisting of components of psycho-education about mood disorders, cognitive and behavioural skills, and relapse prevention and is adapted for the non-clinical population in the current study. The UP will be led and delivered by trained therapists.
Eligibility Criteria
You may qualify if:
- Working in local schools or education institutions
- aged 18 or above
- no severe or unstable mental health conditions at recruitment
- no extensive prior training/practice with mindfulness
You may not qualify if:
- psychotic disorders, bipolar disorder, severe alcohol disorder and substance abuse, acute and high suicidal risk
- currently receiving taking other psychosocial interventions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 14, 2022
First Posted
May 27, 2022
Study Start
November 1, 2021
Primary Completion
May 1, 2023
Study Completion
September 1, 2023
Last Updated
May 27, 2022
Record last verified: 2022-05